Sanofi and Regeneron receives Japanese marketing a...
Category : Approval/Launch 24 December 2025The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authoriz...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
AusperBio completes patient enrollment in phase II...
Category : Clinical Trial Update 24 December 2025AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage b...
Ipsen’s Phase II FALKON Trial Fails to Meet Primar...
Category : Clinical Trial Update 23 December 2025Ipsen has announced a setback in its rare disease pipeline. The company will discontinue the pivotal...
Emcure Launches Poviztra: A New Semaglutide Option...
Category : Clinical Trial Update 23 December 2025India’s obesity burden is rising fast. Emcure Pharmaceuticals is stepping in with a new treatm...
GC Biopharma Secures South Korea IND Approval for...
Category : Clinical Trial Update 23 December 2025GC Biopharma has cleared an important regulatory milestone in South Korea’s mRNA vaccine push....
Latest Newsletter Post
-
AusperBio completes patient enrollm..
24 December 2025
-
Sanofi and Regeneron receives Japan..
24 December 2025
-
GC Biopharma Secures South Korea IN..
23 December 2025
-
Emcure Launches Poviztra: A New Sem..
23 December 2025
-
Ipsen’s Phase II FALKON Trial Fails..
23 December 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com